Single treatment of low-risk basal cell carcinomas with pulsed dye laser-mediated photodynamic therapy (PDL-PDT) compared with photodynamic therapy (PDT): A controlled, investigator-blinded, intra-individual prospective study

Photodiagnosis and Photodynamic Therapy

Volumn 16, Issue , 2016, Pages 60-65

  Čarija, Antoanela ^a,b   Puizina Ivić, Neira ^a,b   Vuković, Dubravka ^a   Mirić Kovačević, Lina ^a   Čapkun, Vesna ^b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

ALA photodynamic therapy; BCC; Non melanoma skin cancers; PDL; Pulsed dye laser mediated photodynamic therapy

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER PAIN; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LIGHT EMITTING DIODE; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULSED DYE LASER; PULSED DYE LASER MEDIATED PHOTODYNAMIC THERAPY; RISK FACTOR; SCORING SYSTEM; THERAPY EFFECT; ADVERSE EFFECTS; CARCINOMA, BASAL CELL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DYE LASER; LOW LEVEL LASER THERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; SINGLE BLIND PROCEDURE; SKIN NEOPLASMS; THERAPEUTIC USE; TREATMENT OUTCOME;

RADIOSENSITIZING AGENT;

AGED; CANCER PAIN; CARCINOMA, BASAL CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LASERS, DYE; LOW-LEVEL LIGHT THERAPY; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; SINGLE-BLIND METHOD; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84987978331     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2016.08.003     Document Type: Article

References (47)

1. [1] Karagas, M.R., Stukel, T.A., Greenberg, E., Baron, J.A., Mott, L.A., Stern RS: Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA 267:24 (1992), 3305–3310.
2. [2] Kiiski, V., de Vries, E., Flohil, S.C., Bijl, M.J., Stricker, B.H., Nijsten, T., RIsk factors for single and multiple basal cell carcinomas. Arch. Dermatol. 146:8 (2010), 848–855.
3. [3] Miller, D.L., Weinstock, M.A., Nonmelanoma skin cancer in the United States: incidence. J. Am. Acad. Dermatol. 30:5 Pt 1 (1994), 774–778.
4. [4] Housman, T.S., Feldman, S.R., Williford, P.M., Fleischer, A.B., Goldman, N.D., Acostamadiedo, J.M., Chen, G.J., Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol. 48:3 (2003), 425–429.
5. [5] Miller, S.J.A.M., Andersen, J., Berg, D., Bichakjian, C.K., Bowen, G., Cheney, R.T., Glass, L.F., Grekin, R.C., Kessinger, A., Lee, N.Y., Liegeois, N., Lydiatt, D.D., Michalski, J., Morrison, W.H., Nehal, K.S., Nelson, K.C., Nghiem, P., Olencki, T., Perlis, C.S., Rosenberg, E.W., Shaha, A.R., Urist, M.M., Wang, L.C., Zic, J.A., Basal cell and squamous cell skin cancers. J. Natl. Compr. Cancer Netw. 8 (2010), 836–864.
6. [6] Telfer, N.R., Colver, G.B., Morton, C.A., Guidelines for the management of basal cell carcinoma. Br. J. Dermatol. 159:1 (2008), 35–48.
7. [7] Cosgarea, R., Susan, M., Crisan, M., Senila, S., Photodynamic therapy using topical 5-aminolaevulinic acid vs: surgery for basal cell carcinoma. J. Eur. Acad. Dermatol. Venereol. 27:8 (2013), 980–984.
8. [8] Kennedy, J.C., Pottier, R.H., Pross, D.C., Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B 6:1-2 (1990), 143–148.
9. [9] Henderson, B.W., Dougherty, T.J., How does photodynamic therapy work?. Photochem. Photobiol. 55:1 (1992), 145–157.
10. [10] Issa, M.C., Manela-Azulay, M., Photodynamic therapy: a review of the literature and image documentation. An. Bras. Dermatol. 85:4 (2010), 501–511.
11. [11] Brightman, L., Warycha, M., Anolik, R., Geronemus, R., Do lasers or topicals really work for nonmelanoma skin cancers?. Semin. Cutan. Med. Surg. 30:1 (2011), 14–25.
12. [12] Sayre, R.M., Dowdy, J.C., Gottschalk, R.W., Comparative effectiveness of clinically used light sources for cutaneous protoporphyrin IX-based photodynamic therapy. J. Cosmet. Laser Ther. 13:2 (2011), 63–68.
13. [13] Strasswimmer, J., Grande, D.J., Do pulsed lasers produce an effective photodynamic therapy response?. Lasers Surg. Med. 38:1 (2006), 22–25.
14. [14] Alexiades-Armenakas, M.R., Geronemus, R.G., Laser-mediated photodynamic therapy of actinic keratoses. Arch. Dermatol. 139:10 (2003), 1313–1320.
15. [15] Alexiades-Armenakas, M.R., Geronemus, R.G., Laser-mediated photodynamic therapy of actinic cheilitis. J. Drugs Dermatol. 3:5 (2004), 548–551.
16. [16] Britton, J.E., Goulden, V., Stables, G., Stringer, M., Sheehan-Dare, R., Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy. Br. J. Dermatol. 153:4 (2005), 780–784.
17. [17] Karrer, S., Baumler, W., Abels, C., Hohenleutner, U., Landthaler, M., Szeimies, R.M., Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg. Med. 25:1 (1999), 51–59.
18. [18] Kim, B.S., Kim, J.Y., Song, C.H., Kim, H.Y., Lee, W.J., Lee, S.J., Kim do, W., Light-emitting diode laser versus pulsed dye laser-assisted photodynamic therapy in the treatment of actinic keratosis and Bowen's disease. Dermatol. Surg. 38:1 (2012), 151–153.
19. [19] Fernandez-Guarino, M., Harto, A., Jaen, P., Pulsed dye laser does not seem as effective as red light in Basal cell carcinoma mal-pdt: a small pilot study. J. Skin Cancer 2012 (2012), 396–481.
20. [20] Kreusch, J.F., Vascular patterns in skin tumors. Clin. Dermatol. 20:3 (2002), 248–254.
21. [21] Allison, K.P., Kiernan, M.N., Waters, R.A., Clement, R.M., Pulsed dye laser treatment of superficial basal cell carcinoma: realistic or not?. Lasers Med. Sci. 18:2 (2003), 125–126.
22. [22] Campolmi, P., Mavilia, L., Bonan, P., Cannarozzo, G., Lotti, T.M., 595 nm pulsed dye laser for the treatment of superficial basal cell carcinoma. Lasers Med. Sci. 20:3–4 (2005), 147–148.
23. [23] Shah, S.M., Konnikov, N., Duncan, L.M., Tannous, Z.S., The effect of 595 nm pulsed dye laser on superficial and nodular basal cell carcinomas. Lasers Surg. Med. 41:6 (2009), 417–422.
24. [24] Shahshahani, M., Ehsani, A., Noormohammadpour, P., Kemiab Hesary, K., Gholamali, F., 595 nm pulsed dye laser: an alternative to treat basal cell carcinomas. J. Lasers Med. Sci. 2:3 (2011), 98–102.
25. [25] Karsai, S., Friedl, H., Buhck, H., Junger, M., Podda, M., The role of the 595-nm pulsed dye laser in treating superficial basal cell carcinoma: outcome of a double-blind randomized placebo-controlled trial. Br. J. Dermatol. 172:3 (2015), 677–683.
26. [26] Tran, H.T., Lee, R.A., Oganesyan, G., Jiang, S.B., Single treatment of non-melanoma skin cancers using a pulsed-dye laser with stacked pulses. Lasers Surg. Med. 44:6 (2012), 459–467.
27. [27] Li, D., Chen, B., Wu, W.J., Wang, G.X., He, Y.L., Ying, Z.X., Experimental study on the vascular thermal response to visible laser pulses. Lasers Med. Sci. 30:1 (2015), 135–145.
28. [28] Kimel, S., Svaasand, L.O., Hammer-Wilson, M., Schell, M.J., Milner, T.E., Nelson, J.S., Differential vascular response to laser photothermolysis. J. Invest. Dermatol. 103:5 (1994), 693–700.
29. [29] Iinuma, S., Schomacker, K.T., Wagnieres, G., Rajadhyaksha, M., Bamberg, M., Momma, T., Hasan, T., In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. Cancer Res. 59:24 (1999), 6164–6170.
30. [30] Roozeboom, M.H., Arits, A.H., Nelemans, P.J., Kelleners-Smeets, N.W., Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials. Br. J. Dermatol. 167:4 (2012), 733–756.
31. [31] Minars, N., Blyumin-Karasik, M., Treatment of basal cell carcinomas with pulsed dye laser: a case series. J. Skin Cancer, 2012, 2012, 6.
32. [32] Ballard, C.J., Rivas, M.P., McLeod, M.P., Choudhary, S., Elgart, G.W., Nouri, K., The pulsed dye laser for the treatment of basal cell carcinoma. Lasers Med. Sci. 26:5 (2011), 641–644.
33. [33] Hohenleutner, U., Hilbert, M., Wlotzke, U., Landthaler, M., Epidermal damage and limited coagulation depth with the flashlamp-pumped pulsed dye laser: a histochemical study. J. Invest. Dermatol. 104:5 (1995), 798–802.
34. [34] Kelly, K.M., Kimel, S., Smith, T., Stacy, A., Hammer-Wilson, M.J., Svaasand, L.O., Nelson, J.S., Combined photodynamic and photothermal induced injury enhances damage to in vivo model blood vessels. Lasers Surg. Med. 34:5 (2004), 407–413.
35. [35] Soler, A.M., Warloe, T., Tausjo, J., Berner, A., Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Derm. Venereol. 79:3 (1999), 204–206.
36. [36] Togsverd-Bo, K., Idorn, L.W., Philipsen, P.A., Wulf, H.C., Haedersdal, M., Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources. Exp. Dermatol. 21:10 (2012), 745–750.
37. [37] Wang, H., Xu, Y., Shi, J., Gao, X., Geng, L., Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta- analysis. Photodermatol. Photoimmunol. Photomed. 31:1 (2015), 44–53.
38. [38] Vinciullo, C., Elliott, T., Francis, D., Gebauer, K., Spelman, L., Nguyen, R., Weightman, W., Sheridan, A., Reid, C., Czarnecki, D., Murrell, D., Photodynamic therapy with topical methyl aminolaevulinate for ‘difficult-to-treat' basal cell carcinoma. Br. J. Dermatol. 152:4 (2005), 765–772.
39. [39] Fantini, F., Greco, A., Del Giovane, C., Cesinaro, A.M., Venturini, M., Zane, C., Surrenti, T., Peris, K., Calzavara-Pinton PG: Photodynamic therapy for basal cell carcinoma: clinical and pathological determinants of response. J. Eur. Acad. Dermatol. Venereol. 25:8 (2011), 896–901.
40. [40] de Haas, E.R., de Vijlder, H.C., Sterenborg, H.J., Neumann, H.A., Robinson, D.J., Fractionated aminolevulinic acid- photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. J. Eur. Acad. Dermatol. Venereol. 22:4 (2008), 426–430.
41. [41] Horn, M., Wolf, P., Wulf, H.C., Warloe, T., Fritsch, C., Rhodes, L.E., Kaufmann, R., De Rie, M., Legat, F.J., Stender, I.M., Soler, A.M., Wennberg, A.M., Wong, G.A., Larko, O., Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br. J. Dermatol. 149:6 (2003), 1242–1249.
42. [42] Randle, H.W., Basal cell carcinoma: identification and treatment of the high-risk patient. Dermatol. Surg. 22:3 (1996), 255–261.
43. [43] Souza, C.S., Felicio, L.B., Ferreira, J., Kurachi, C., Bentley, M.V., Tedesco, A.C., Bagnato, V.S., Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer. Photodiagn. Photodyn. 6:3–4 (2009), 207–213.
44. [44] van Oosten, E.J., Kuijpers, D.I., Thissen MR: Different pain sensations in photodynamic therapy of nodular basal cell carcinoma Results from a prospective trial and a review of the literature. Photodiagn. Photodyn. 3:1 (2006), 61–68.
45. [45] Zeitouni, N.C., Paquette, A.D., Housel, J.P., Shi, Y., Wilding, G.E., Foster, T.H., Henderson, B.W., A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer. Lasers Surg. Med. 45:2 (2013), 89–94.
46. [46] Warren, C.B., Karai, L.J., Vidimos, A., Maytin, E.V., Pain associated with aminolevulinic acid-Photodynamic therapy of skin disease. J. Am. Acad. Dermatol. 61:6 (2009), 1033–1043.
47. [47] L.R. Braathen, R-M. Szeimies, N. Basset-Seguin, R. Bissonnette, P. Foley, D. Pariser, R. Roelandts, A.M. Wennberg, C.A. Morton, Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: An international consensus, J. Am. Acad. Dermatol. 56 (1) 125–143.